Literature DB >> 17090701

Surfactant protein A binds to IgG and enhances phagocytosis of IgG-opsonized erythrocytes.

Peggy M Lin1, Jo Rae Wright.   

Abstract

Surfactant protein (SP)-A and SP-D, immunoglobulins, and complement all modulate inflammation within the lung by regulating pathogen clearance. For example, SP-A binds to and opsonizes a variety of bacteria and viruses, thereby enhancing their phagocytosis by innate immune cells such as alveolar macrophages. Immunoglobulins, which bind to antigen and facilitate Fc receptor-mediated phagocytosis, can also activate complement, a family of soluble proteins with multiple host defense functions. Previous studies showed that SP-A and complement protein C1q interact. Since complement protein C1q binds to IgG and IgM immune complexes, the hypothesis tested in this study was that SP-A, which is structurally homologous to C1q, also binds to IgG and affects its functions. SP-A binds to the Fc, rather than the Fab, region of IgG. Binding is calcium dependent but not inhibited by saccharides known to bind to SP-A's carbohydrate recognition domain. The binding of SP-A does not inhibit the formation of immune complexes or the binding of IgG to C1q. In contrast, SP-A enhances the uptake of IgG-coated erythrocytes, suggesting that SP-A might be influencing Fc receptor-mediated uptake. In summary, this study shows a novel interaction between SP-A and IgG and a functional consequence of the binding.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17090701     DOI: 10.1152/ajplung.00188.2006

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  8 in total

1.  Surfactant protein-A (SP-A) selectively inhibits prostaglandin F2alpha (PGF2alpha) production in term decidua: implications for the onset of labor.

Authors:  Victoria V Snegovskikh; Vineet Bhandari; Jo Rae Wright; Serkalem Tadesse; Thomas Morgan; Colin Macneill; Nastaran Foyouzi; Joong Shin Park; Yuguang Wang; Errol R Norwitz
Journal:  J Clin Endocrinol Metab       Date:  2011-01-26       Impact factor: 5.958

Review 2.  Structure, genetics and function of the pulmonary associated surfactant proteins A and D: The extra-pulmonary role of these C type lectins.

Authors:  Frederico Vieira; Johannes W Kung; Faizah Bhatti
Journal:  Ann Anat       Date:  2017-03-27       Impact factor: 2.698

3.  Dispensability of surfactant proteins A and D in immune control of Mycobacterium tuberculosis infection following aerosol challenge of mice.

Authors:  Maria P Lemos; John McKinney; Kyu Y Rhee
Journal:  Infect Immun       Date:  2011-01-03       Impact factor: 3.441

4.  OSCAR is a receptor for surfactant protein D that activates TNF-α release from human CCR2+ inflammatory monocytes.

Authors:  Alexander D Barrow; Yaseelan Palarasah; Mattia Bugatti; Alex S Holehouse; Derek E Byers; Michael J Holtzman; William Vermi; Karsten Skjødt; Erika Crouch; Marco Colonna
Journal:  J Immunol       Date:  2015-02-25       Impact factor: 5.422

Review 5.  SP-A and SP-D: Dual Functioning Immune Molecules With Antiviral and Immunomodulatory Properties.

Authors:  Alastair Watson; Jens Madsen; Howard William Clark
Journal:  Front Immunol       Date:  2021-01-19       Impact factor: 7.561

6.  Pneumocystis murina colonization in immunocompetent surfactant protein A deficient mice following environmental exposure.

Authors:  Michael J Linke; Alan D Ashbaugh; Jeffery A Demland; Peter D Walzer
Journal:  Respir Res       Date:  2009-02-19

7.  Cryptococcus neoformans is resistant to surfactant protein A mediated host defense mechanisms.

Authors:  Steven S Giles; Aimee K Zaas; Mike F Reidy; John R Perfect; Jo Rae Wright
Journal:  PLoS One       Date:  2007-12-26       Impact factor: 3.240

Review 8.  Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy.

Authors:  Carlos Cruz-Teran; Karthik Tiruthani; Morgan McSweeney; Alice Ma; Raymond Pickles; Samuel K Lai
Journal:  Adv Drug Deliv Rev       Date:  2020-12-09       Impact factor: 17.873

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.